Howe & Rusling’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-46
Closed -$4K 1110
2016
Q3
$4K Hold
46
﹤0.01% 748
2016
Q2
$4K Buy
46
+5
+12% +$357 ﹤0.01% 723
2016
Q1
$2K Buy
41
+2
+5% +$109 ﹤0.01% 912
2015
Q4
$2K Hold
39
﹤0.01% 881
2015
Q3
$2K Buy
39
+7
+22% +$500 ﹤0.01% 881
2015
Q2
$2K Hold
32
﹤0.01% 914
2015
Q1
$2K Buy
32
+7
+28% +$465 ﹤0.01% 815
2014
Q4
$2K Buy
+25
New +$1.61K ﹤0.01% 811
2014
Q2
Sell
-199
Closed -$13K 970
2014
Q1
$13K Sell
199
-12
-6% -$781 ﹤0.01% 536
2013
Q4
$13K Hold
211
﹤0.01% 461
2013
Q3
$11K Buy
+211
New +$10.9K ﹤0.01% 588

Other funds holding STJ

Howe & Rusling's STJ Position: Q4 2016 in Review

Howe & Rusling sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 46 shares — an estimated $4K sold.

Howe & Rusling first reported a position in STJ in Q3 2013 and held it in 11 quarters. The position peaked at $13K in Q1 2014. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Howe & Rusling reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Howe & Rusling sold 46 St Jude Medical shares in Q4 2016, an estimated $4K.
  • Howe & Rusling first reported a position in St Jude Medical in Q3 2013 and held it in 11 quarters.
  • Howe & Rusling's St Jude Medical position peaked at $13K in Q1 2014.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Howe & Rusling's 13F filing for Q4 2016, filed 20 Jan 2017.